Zdrowie i gospodarka · 27/08/2012

FDA Releases Draft Guidance on Generic Drug User Fee Amendments of 2012

The US Food and Drug Administration (FDA) has published a draft guidance document addressing questions and concerns from the generic pharmaceutical industry regarding the Generic Drug User Fee Amendments of 2012 (GDUFA), a law aimed at accelerating the development and approval of generic drugs while reducing industry costs.